DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Elyasi S, Shojaee FSR, Allahyari A. et al.
Topical Silymarin Administration for Prevention of Capecitabine-Induced
Hand–Foot Syndrome: A Randomized, Double-Blinded,
Placebo-Controlled Clinical Trial.
Phyther Res 2017;
31: 1323-1329
DOI: 10.1002/ptr.5857.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.